The Food and Drug Administration is defending its choice not to move forward with reviewing a therapy for a rare brain issue called Huntington’s disease. A trial of uniQure’s AMT-130 gene therapy is ...
Primoris Services Corp. is a holding company, which engages in the provision of construction, fabrication, maintenance, replacement, and engineering services. It operates through the Utilities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results